Use of Home-Based Subcutaneous Immunoglobulin Therapy in Elderly Patients With Primary Immunodeficiency Diseases

被引:1
|
作者
Guthrie, Robert M. [1 ]
机构
[1] Ohio State Univ, Columbus, OH 43210 USA
关键词
D O I
10.3810/pgm.2013.01.2632
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:169 / 171
页数:3
相关论文
共 50 条
  • [21] SWITCHING PATIENTS WITH PRIMARY ANTIBODY DEFICIENCIES TO HOME-BASED SUBCUTANEOUS IMMUNOGLOBULIN: ECONOMIC EVALUATION OF AN INTERPROFESSIONAL DRUG THERAPY MANAGEMENT PROGRAM
    Perraudin, C.
    Bourdin, A.
    Berger, J.
    Bugnon, O.
    VALUE IN HEALTH, 2014, 17 (07) : A424 - A424
  • [22] Facilitated subcutaneous immunoglobulin treatment patterns in pediatric patients with primary immunodeficiency diseases
    Mach-Tomalska, Monika
    Pituch-Noworolska, Anna
    Bien, Ewa
    Malanowska, Magdalena
    Machura, Edyta
    Pukas-Bochenek, Anna
    Chrobak, Ewelina
    Pac, Malgorzata
    Pietrucha, Barbara
    Drygala, Szymon
    Kamieniak, Marta
    Kasprzak, Jakub
    Heropolitanska-Pliszka, Edyta
    IMMUNOTHERAPY, 2024, 16 (06) : 391 - 403
  • [23] Subcutaneous immunoglobulin use in immunoglobulin-naive patients with primary immunodeficiency: a systematic review
    Anderson-Smits, Colin
    Park, Michelle
    Bell, Judith
    Mitchell, Sarah
    Hartley, Louise
    Hawe, Emma
    IMMUNOTHERAPY, 2022, 14 (05) : 373 - 387
  • [24] Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis
    Fu, Lisa W.
    Song, Christine
    Isaranuwatchai, Wanrudee
    Betschel, Stephen
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (02) : 195 - 199
  • [25] PROSPECTIVE ECONOMIC ANALYSIS OF HOME-BASED SUBCUTANEOUS IMMUNOGLOBULIN THERAPY VS HOSPITAL-BASED INTRAVENOUS IMMUNOGLOBULIN THERAPY
    Fu, L.
    Song, C.
    Betschel, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S96 - S96
  • [26] Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program
    Clemence Perraudin
    Aline Bourdin
    Francois Spertini
    Jérôme Berger
    Olivier Bugnon
    Journal of Clinical Immunology, 2016, 36 : 502 - 510
  • [27] Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program
    Perraudin, Clemence
    Bourdin, Aline
    Spertini, Francois
    Berger, Jerome
    Bugnon, Olivier
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (05) : 502 - 510
  • [28] INITIATION OF 20% SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY NAIVE TO IG THERAPY
    Duff, Carla
    Leiding, Jennifer W.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 208 - 208
  • [29] Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases
    Kobayashi, Roger H.
    Litzman, Jiri
    Rizvi, Syed
    Kreuwel, Huub
    Hoeller, Sonja
    Gupta, Sudhir
    IMMUNOTHERAPY, 2022, 14 (04) : 259 - 270
  • [30] Compliance with Immunoglobulin Therapy In Patients with Primary Immunodeficiency (PIDD) Treated at Home
    Bonnet, P. O.
    Yoon, A. H.
    Xiong, Y.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB18 - AB18